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1. General Information 
Toluene was dried by Sodium, distilled under reduced pressure and stored under nitrogen. Pd(OAc)2 
(Stream), Ag2CO3 (Adamas) were purchased from above mentioned company and used without 
additional purification. Other chemical reagents were commercially available and directly used 
without any further purification. NMR spectra were recorded on a Bruke Avance operating for 1H 
NMR at 400 MHz, 13C NMR at 100 MHz, and 19F NMR at 376 MHz, using TMS as internal standard. 
The peaks were internally referenced to TMS (0.00 ppm) or residual undeuterated solvent signal 
(77.16 ppm for 13C NMR). The following abbreviations (or combinations thereof) were used to 
explain multiplicities: s = singlet, d = doublet, t = triplet, m = multiplet, b = broad. Mass 
spectroscopy data of the products were collected on an HRMS-TOF instrumentor a low-resolution 
MS instrument using EI ionization and ESI ionization. 
 
 
 
 
 
 
 
 
 
 
  
S3 
 
2. Experimental Section 
2.1 Praperation of Substrates 
General Procedure for the Synthesis of 2a-2j via Pd-Catalyzed Monoarylation of 
Alanine Derivative 1[1] 
 
To a 100-mL vial was added 1 (690.7 mg, 2.0 mmol), Pd(OAc)2 (44.5 mg, 0.2 mmol), aryl iodide 
(2.4 mmol, for several specific reactions, 3.0 mmol of aryl iodide was used), AgBF4 (506.2 mg, 2.6 
mmol), and t-BuOH/DCE (10 mL + 5 mL). The mixture was stirred at 75 oC for 4 hours (for several 
specific substrates, the reactions were stirred for 24 hours). After cooling to room temperature, the 
reaction was diluted with dichloromethane (50 mL) and triethylamine (2 mL) was added to the 
mixture. After the mixture was maintained for 6 hours, it was then filtered through a pad of Celite 
and washed by dichloromethane (60 mL). The filtrate was washed by water (50 mL), and the 
aqueous phase was extracted with dichloromethane (2 × 30 mL). The combined organic phase was 
then washed by brine (50 mL), and dried over anhydrous MgSO4. Evaporation of organic solvent 
and purification by column chromatography gave the corresponding product 2a-2j. 2a-2j are known 
compounds.[1] 
 
General Procedure for the Synthesis of 2k via Pd-Catalyzed Alkylation of Alanine 
Derivative 1[2] 
 
To a 30- mL resealable Schlenk flask was added N-phthaloyl-alanine 8-aminoquinoline amide (1) 
(0.2 mmol), Pd(OAc)2 (4.5 mg, 0.02 mmol), iodomethane (0.3 mmol), Ag2CO3 (0.16 mmol), 
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(BnO)2POOH (0.06 mmol), DCE/t-BuOH (1.5 mL, v/v = 1:1). The flask was then charged with N2. 
The mixture was stirred at 50oC for 2 hours under N2. After cooling to room temperature, the 
reaction was diluted with dichloromethane (5 mL) and then filtered through a pad of Celite and 
washed by dichloromethane (30 mL). Evaporation of organic solvent and purification by column 
chromatography gave the corresponding product 2k. 2k is known compound.[2] 
 
General Procedure for synthesis of compound 5[3] 
Compounds 5d, 5h, 5j and 5t were prepared from the corresponding carboxylic acids and 8-
aminoquinoline (8-AQ). Other Compounds (5a-5c, 5e-5g, 5i, 5k-5s, 5u and 5v) are known 
compounds.[3]  
OH
O 1) (COCl)2 , DMF (cat.)
2) DMAP, Et3N , 8-AQ
NH
O
R
N
R
 
The corresponding carboxylic acid (10 mmol) was treated with (COCl)2 (12 mmol, 1.2 equiv) and 
DMF (0.1 mL) in DCM (30 mL) and stirred at room temperature overnight under N2. Then, the 
remained (COCl)2 and solvent were removed by evaporation. The residue acyl chloride was diluted 
with DCM (20 mL) for further use. To a stirring solution of 8-aminoquinoline (8-AQ, 10 mmol, 1.0 
equiv), Et3N (12 mmol) and DMAP (1.0 mmol, 10 mol%) in DCM (30 mL) was added dropwise 
the solution of acyl chloride in DCM at 0-5°C under nitrogen atmosphere. After the addition, the 
resulting mixture was warmed to room temperature and stirred overnight. The reaction was 
quenched with water at 0 oC and diluted with DCM (30 mL). The resulting solution was washed 
sequentially by aqueous HCl (20 mL, 1.0 M), saturated aqueous NaHCO3 (20 mL) and brine (20 
mL). The organic phase was dried over anhydrous MgSO4 and then evaporated under vacuum. The 
residue was purified by column chromatography to afford the aliphatic amide. 
 
2-(2-chlorophenyl)-N-(quinolin-8-yl)propanamide 5d 
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1H NMR (400 MHz, CDCl3) δ 10.00 (br, 1H), 8.75 (d, J = 7.2 Hz, 1H), 8.71 (d, J = 2.8 Hz, 1H), 8.08 
(d, J = 8.0 Hz, 1H), 7.57 (d, J = 7.6 Hz, 1H), 7.51-7.36 (m, 4H), 7.29 (t, J = 7.6 Hz, 1H), 7.20 (t, J = 7.6 
Hz, 1H), 4.48 (q, J = 6.8 Hz, 1H), 1.68 (d, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 171.89, 
148.31, 138.69, 138.56, 136.26, 134.67, 133.89, 129.80, 128.69, 128.55, 127.95, 127.61, 127.39, 121.64, 
121.62, 116.45, 44.49, 17.73. 
 
2-(4-methoxyphenyl)-N-(quinolin-8-yl)propanamide 5h 
1H NMR (400 MHz, CDCl3) δ 9.88 (br, 1H), 8.76 (d, J = 7.6 Hz, 1H), 8.70 (dd, J = 2.4, 1.2 Hz, 
1H), 8.09 (d, J = 8.0 Hz, 1H), 7.52-7.37 (m, 5H), 6.91 (d, J = 7.6 Hz, 2H), 3.88 (q, J = 6.8, 1H), 
3.79 (s, 3H), 1.66 (d, J = 7.2, 3H); 13C NMR (100 MHz, CDCl3) δ = 173.19, 158.97, 148.22, 138.58, 
136.33, 134.70, 133.37, 128.82, 127.97, 127.45, 121.59, 121.48, 116.34, 114.45, 77.48, 77.16, 76.84, 
55.41, 47.91, 18.83. 
  
2-(naphthalen-1-yl)-N-(quinolin-8-yl)propanamide 5j 
1H NMR (400 MHz, CDCl3) δ 9.81 (br, 1H), 8.77 (d, J = 7.6 Hz, 1H), 8.50 (d, J = 3.6 Hz, 1H), 8.24 
(d, J = 8.4 Hz, 1H), 8.02 (d, J = 8.0 Hz, 1H), 7.88 (d, J = 8.0 Hz, 1H), 7.82 (d, J = 8.0 Hz, 1H), 7.70 (d, 
J = 7.2 Hz, 1H), 7.57-7.46 (m, 4H), 7.40 (d, J = 8.0 Hz, 1H), 7.28 (dd, J = 8.0, 4.0 Hz, 1H), 4.70 (dd, J 
= 13.6, 6.4 Hz, 1H), 1.86 (d, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 173.23, 148.14, 138.54, 
137.03, 136.16, 134.67, 134.29, 131.80, 129.16, 128.22, 127.89, 127.39, 126.70, 125.91, 125.04, 123.44, 
121.52, 121.48, 116.27, 45.04, 18.33. 
 
3-(2-chlorophenyl)-2-methyl-N-(quinolin-8-yl)propanamide 5t 
1H NMR (400 MHz, CDCl3) δ 9.79 (br, 1H), 8.79-8.75 (m, 2H), 8.12 (d, J = 8.0 Hz, 1H), 7.54-7.46 (m, 
2H), 7.42 (dd, J = 8.2, 4.2 Hz, 1H), 7.35 (m, 1H), 7.28 (dd, J = 5.4, 3.8 Hz, 1H), 7.10 (dd, J = 5.7, 3.5 
Hz, 2H), 3.30 (dd, J = 12.9, 6.5 Hz, 1H), 2.99 (ddd, J = 29.1, 13.4, 7.1 Hz, 2H), 1.36 (d, J = 6.6 Hz, 3H); 
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13C NMR (100 MHz, CDCl3) δ 174.37, 148.23, 138.54, 137.45, 136.37, 134.63, 134.31, 131.75, 129.69, 
127.99, 127.50, 126.87, 121.66, 121.52, 116.57, 42.78, 38.24, 17.72.
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2.2 Optimized Reaction Conditions 
2.2.1 Optimization of Conditions for the Synthesis of β-TMS-L-Ala via 
Pd(II)-Catalyzed Primary C-H Silylation  
 
Table S1. Optimization of primary C-H silylation: screening of solvents 
Entrya Solvent Yieldb of 1a/1
1
2
3
4
5
dioxane
toluene
PhCl
14%/78%
12%/80%
41%/55%
44%/52%
18%/76%
a The reactions were carried out with 1 (0.15 mmol), hexamethyldisilane (0.75 mmol), Pd(OAc)2
(0.01 mmol), MesCO2H (0.02 mmol), Ag2CO3 (0.3 mmol), solvent (1.0 mL), air, 140 oC, 12 h. b
Yield of 1H NMR. ND = No detection.
DCE
p-xylene
Pd(OAc)2 (10 mol%)
Ag2CO3(2.0 equiv.)
Solvent
MesCO2H (20 mol%)
Me3Si SiMe3
1 1a
NH
O
Q
NPhth
H
H
NH
O
Q
NPhth
TMS
H
6
7
8
9
10
t-AmylOH
THF
63%/30%
61%/36%
trace
ND.
30%/63%
t-BuOH
DMSO
DMF
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Table S2. Optimization of primary C-H silylation: screening of ligands 
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2.2.2 Optimization of Conditions for the Synthesis of β-silyl-α-AAs via 
Pd(II)-Catalyzed Secondary C-H Silylation  
 
Table S3. Optimization of the reaction conditions for secondary C-H silylation 
a The reactions were carried out with 2a (0.1 mmol), hexamethyldisilane (0.5 mmol), Pd(OAc)2
(0.015 mmol), air, 125 oC, 12 h; b Yield of 1H NMR; c Determined by 1H NMR.
NPhth
O
NHPh solvents
oxidants, additives
[SiMe3]2
2a 3a
Entrya Yieldb of 3a/2a
1
2
3
4
5 2.0 eq.
trace
trace
Ag2CO3
standard reaction condition of primary C–H silylation
2.0 eq.
2.0 eq.
2.0 eq.
6
7
8
28%/59%
34%/36%
32%/46%
2.0 eq.
2.0 eq.
2.0 eq.
H
NPhth
O
NHPh
TMS
0.10 eq.
Pd(OAc)2
0.10 eq.
0.10 eq.
0.10 eq.
0.10 eq.
0.10 eq.
0.10 eq.
(BnO)2PO2H (0.2)
Additives (x eq.)
---
---
NaHCO3 (1.0)
BQ (0.2)
2,6-diCl-BQ (0.2)
2,6-diOMe-BQ (0.2)
1,4-dioxane
Solvents
1,4-dioxane
1,4-dioxane
1,4-dioxane
1,4-dioxane
9
10 2.0 eq.
45%/35%
60%/22%
2.0 eq.
11 71%/11%0.5 eq.
0.15 eq.
0.15 eq.
0.15 eq.
2,6-diOMe-BQ (1.5)
2,6-diOMe-BQ (0.3)
2,6-diOMe-BQ (1.5)
1,4-dioxane
1,4-dioxane
1,4-dioxane
1,4-dioxane
NDt-BuOH
23%/68%
ND
dr/3ac
---
---
>20:1
>20:1
>20:1
>20:1
>20:1
>20:1
---
>20:1
---
Pd(OAc)2Q Q
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2.2.3 Optimization of Conditions for Pd(II)-Catalyzed Silylation of 
Primary C-H Bonds of Simple Aliphatic Propionic Acid Derivatives.  
 
Table S4. Screening of solvents 
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Table S5. Screening of bases 
 
  
S12 
 
Table S6. Screening of ligands 
 
S13 
 
Table S7. Screening of additives 
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Table S8. Screening of the equivalent of LiOAc 
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2.3 General Procedures for Pd-Catalyzed C(sp3)‒H Silylation  
2.3.1 General Procedure for the synthesis of β-TMS-L-Ala via Pd-Catalyzed 
Silylation of Primary C‒H Bonds (GP1) 
 
To an oven-dried 50 mL screw-capped vial was added substrate 1 (0.1 mmol), hexamethyldisilane 
(0. 5 mmol), Pd(OAc)2 (2.3 mg, 0.01 mmol), N-Boc-L-Val-OH (0.02 mmol), Ag2CO3 (56 mg, 0.2 
mmol), tBuOH (1.0 mL). The mixture was stirred for 12 h at 125 °C under air followed by cooling. 
The resulting mixture was filtered through a celite pad and concentrated in vacuo. The residue was 
purified by preparative TLC using hexane/EtOAc as the eluent to afford the product 1a. 
 
(R)-2-(1,3-dioxoisoindolin-2-yl)-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 1a 
1H NMR (400 MHz, CDCl3) δ 10.47 (br, 1H), 8.74-8.70 (m, 2H), 8.14 (dd, J = 8.4, 1.2 Hz, 1H), 
7.90 (dd, J = 5.2, 3.2 Hz, 2H), 7.75 (dd, J = 5.2, 3.2 Hz, 2H), 7.50 (d, J = 4.8 Hz, 2H), 7.42 (dd, J = 
8.0, 4.0 Hz, 1H), 5.23 (dd, J = 12.0, 4.8 Hz, 1H), 2.08 (dd, J = 14.4, 12.0 Hz, 1H), 1.66 (dd, J = 
14.4, 4.8 Hz, 1H), 0.05 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 168.41, 168.19, 148.50, 138.77, 
136.40, 134.34, 134.21, 132.11, 128.03, 127.45, 123.73, 121.98, 121.73, 116.77, 52.41, 17.31, -1.31; 
HRMS (ESI-TOF) calcd for C23H23ClN3O3Si (M+): 417.1509, found: 417.1515; HPLC 
Chiralpack® AD-H column (n-hexane/isopropanol = 70:30, 1.0 mL/min) tr = 8.794 min (major), tr 
= 10.062 min (minor): 98% ee. 
DL-/L-1 were prepared following the literature procedure.[1]  
1: HPLC Chiralpack® AD-H column (n-hexane/isopropanol = 70:30, 1.0 mL/min) tr = 14.327 min 
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(major), tr = 15.869 min (minor): 99% ee. 
DL-/L-1 
 
Chiral stationary phase: Chiralpack® AD-H, n-hexane/isopropanol = 70:30, 1.0 mL/min  
Signal: VWD1 A, Wavelength = 220 nm 
      
Area% report for DL/L-1: 
DL-1 L-1 
Retention Time 
(min) 
Area 
(mAU*s) Area %
Retention Time 
(min) Area (mAU*s) 
Area 
% 
15.150 1844084 50.12 14.327 20005334 99.77
16.942 1834941 49.88 15.869 46570 0.23 
Totals 3679025 100.00 Totals 20051903 100.00
 
DL-/L-1a 
N NH
O
O
O
SiMe3 N  
Chiral stationary phase: Chiralpack® AD-H, n-hexane/isopropanol = 70:30, 1.0 mL/min  
Signal: VWD1 A, Wavelength = 220 nm 
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Area% report for DL/L-1a: 
DL-1a L-1a 
Retention Time 
(min) 
Area 
(mAU*s) Area %
Retention Time 
(min) Area (mAU*s) 
Area 
% 
8.428 2237629 50.15 8.794 2054366 99.19
9.684 2224580 49.85 10.062 16836 0.81 
Totals 4462209 100.00 Totals 2071202 100.00
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2.3.2 General Procedure for the Synthesis of Chiral β-silyl-α-AAs via Pd-
Catalyzed Silylation of Secondary C‒H Bonds (GP2) 
 
To an oven-dried 50 mL screw-capped vial was added substrate 2 (0.1 mmol), hexamethyldisilane 
(0. 5 mmol), Pd(OAc)2 (3.5 mg, 0.015 mmol), Ag2CO3 (13.8 mg, 0.5 mmol), 2,6-diMeO-BQ (25.2 
mg, 0.15 mmol), 1,4-dioxane (1.0 mL). The mixture was stirred for 12 h at 125 °C under air followed 
by cooling. The resulting mixture was filtered through a celite pad and concentrated in vacuo. The 
residue was purified by preparative TLC using hexane/EtOAc as the eluent to afford the product 
chiral β-silyl-α-amino acids 3.  
 
(2R,3S)-2-(1,3-dioxoisoindolin-2-yl)-3-phenyl-N-(quinolin-8-yl)-3-
(trimethylsilyl)propanamide 3a 
1H NMR (400 MHz, CDCl3) δ 10.93 (br, 1H), 8.93 (dd, J = 4.0, 1.6 Hz, 1H), 8.82-8.77 (m, 1H), 
8.14 (dd, J = 8.4, 1.6 Hz, 1H), 7.69 (m, 2H), 7.57 (td, J = 5.2, 2.0 Hz, 2H), 7.53 (d, J = 1.6 Hz, 1H), 
7.52 (s, 1H), 7.46 (dd, J = 8.4, 4.0 Hz, 1H), 7.25-7.17 (m, 4H), 6.95 (ddd, J = 8.8, 5.2, 3.6 Hz, 1H), 
5.60 (d, J = 13.6 Hz, 1H), 3.89 (d, J = 13.6 Hz, 1H), 0.02 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
168.26, 167.32, 148.81, 139.66, 138.98, 136.27, 134.61, 134.04, 131.37, 128.37, 128.07, 127.37, 
125.54, 123.41, 122.26, 121.76, 117.46, 59.32, 36.53, -1.88; HRMS (ESI-TOF) calcd for 
C29H28N3O3Si (M+H)+: 494.1894, found: 494.1901; HPLC Chiralpack® AD-H column (n-
hexane/isopropanol = 70:30, 1.0 mL/min) tr = 13.317 min (minor), tr = 10.062 min (major): 97% ee. 
L-2a: HPLC Chiralpak® AD-H column (n-hexane/isopropanol = 55:45, 0.90 
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mL/min), tr = 16.176 (minor), tr = 24.049 (major), 98% ee.[1] 
DL-/L-3a 
 
Chiral stationary phase: Chiralpack® AD-H, n-hexane/isopropanol = 70:30, 1.0 mL/min  
Signal: VWD1 A, Wavelength = 220 nm 
      
Area% report for DL/L-3a: 
DL-3a L-3a 
Retention Time 
(min) 
Area 
(mAU*s) Area %
Retention Time 
(min) Area (mAU*s) 
Area 
% 
7.305 5431386 49.78 7.253 797902 1.16 
13.698 5479700 50.22 13.317 68066708 98.84
Totals 10911086 100.00 Totals 68864611 100.00
 
 
(2R,3S)-2-(1,3-dioxoisoindolin-2-yl)-3-(4-methoxyphenyl)-N-(quinolin-8-yl)-3-
(trimethylsilyl)propanamide 3b 
1H NMR (400 MHz, CDCl3) δ 10.93 (br, 1H), 8.94 (d, J = 2.8 Hz, 1H), 8.80-8.78 (m, 1H), 8.15 (d, 
J = 7.2 Hz, 1H), 7.70 (dd, J = 5.2, 3.2 Hz, 2H), 7.58 (dd, J = 5.2, 3.2 Hz, 2H), 7.52 (d, J = 4.4 Hz, 
2H), 7.46 (dd, J = 8.0, 4.0 Hz, 1H), 7.02 (d, J = 8.4 Hz, 2H), 6.67 (d, J = 8.4 Hz, 2H), 5.53 (d, J = 
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13.6 Hz, 1H), 3.82 (d, J = 13.6 Hz, 1H), 3.66 (s, 3H), 0.01 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
168.32, 167.42, 157.41, 148.81, 139.00, 136.27, 134.64, 134.07, 131.53, 131.43, 128.08, 127.38, 
123.46, 122.25, 121.76, 117.48, 113.85, 59.55, 55.18, 35.41, -1.88; HRMS (ESI-TOF) calcd for 
C30H30N3O4Si (M+H)+: 524.2000, found: 524.2003. 
 
(2R,3S)-3-(4-acetamidophenyl)-2-(1,3-dioxoisoindolin-2-yl)-N-(quinolin-8-yl)-3-
(trimethylsilyl)propanamide 3c 
1H NMR (400 MHz, CDCl3) δ 10.85 (br, 1H), 8.91 (dd, J = 4.02, 1. Hz, 1H),8.80- 8.75 (m, 1H), 
8.15 (dd, J = 8.4, 1.2 Hz, 1H), 7.75 (d, J = 8.4 Hz, 2H), 7.69 (dt, J = 7.2, 3.6 Hz, 2H), 7.58 (dd, J = 
5.2, 3.2 Hz, 2H), 7.52 (d, J = 4.4 Hz, 2H), 7.46 (dd, J = 8.4, 4.0 Hz, 1H), 7.21 (d, J = 8.4 Hz, 2H), 
5.63 (d, J = 13.6 Hz, 1H), 4.06 (d, J = 13.6 Hz, 1H), 2.47 (s, 3H), 0.03 (s, 9H); 13C NMR (100 MHz, 
CDCl3) δ 197.88, 168.12, 166.77, 148.83, 146.16, 138.89, 136.31, 134.66, 134.41, 134.25, 131.20, 
128.62, 128.05, 127.35, 123.58, 122.40, 121.82, 117.44, 58.52, 37.09, 26.54, -1.93; HRMS (ESI-
TOF) calcd for C31H31N4O4Si (M+H)+: 551.2109, found: 551.2124. 
 
(2R,3S)-2-(1,3-dioxoisoindolin-2-yl)-N-(quinolin-8-yl)-3-(p-tolyl)-3-
(trimethylsilyl)propanamide 3d 
1H NMR (400 MHz, CDCl3) δ 10.93 (br, 1H), 8.94 (dd, J = 4.0, 1.6 Hz, 1H), 8.79 (dd, J = 5.2, 3.6 
Hz, 1H), 8.14 (dd, J = 8.4, 1.6 Hz, 1H), 7.71-7.69 (m, 2H), 7.59-7.56 (m, 2H), 7.52-7.51 (m, 2H), 
7.46 (dd, J = 8.4, 4.4 Hz, 1H), 6.99 (d, J = 8.4 Hz, 2H), 6.91 (d, J = 7.6 Hz, 2H), 5.57 (d, J = 13.6 
Hz, 1H), 3.85 (d, J = 13.6 Hz, 1H), 2.14 (s, 3H), 0.01-0.00 (m, 9H); 13C NMR (100 MHz, CDCl3) 
δ 168.29, 167.44, 148.80, 138.98, 136.30, 136.26, 134.86, 134.63, 133.99, 131.45, 129.08, 128.06, 
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127.36, 123.43, 122.24, 121.75, 117.46, 59.48, 35.96, 20.99, -1.88; HRMS (ESI-TOF) calcd for 
C30H30N3O3Si (M+H)+: 508.2051, found: 508.2056. 
 
(2R,3S)-2-(1,3-dioxoisoindolin-2-yl)-3-(4-ethylphenyl)-N-(quinolin-8-yl)-3-
(trimethylsilyl)propanamide 3e 
1H NMR (400 MHz, CDCl3) δ 10.94 (br, 1H), 8.93 (dd, J = 4.0, 1.6 Hz, 1H), 8.80 (dd, J = 5.6, 3.2 
Hz, 1H), 8.13 (dd, J = 8.4, 1.6 Hz, 1H), 7.68 (dd, J = 5.6, 3.2 Hz, 2H), 7.56 (td, J = 5.2, 2.0 Hz, 2H), 
7.52 (t, J = 2.4 Hz, 1H), 7.51 (s, 1H), 7.45 (dd, J = 8.4, 4.0 Hz, 1H), 7.00 (d, J = 8.4 Hz, 2H), 6.92 
(d, J = 8.0 Hz, 2H), 5.57 (d, J = 13.6 Hz, 1H), 3.84 (d, J = 13.6 Hz, 1H), 2.43 (q, J = 7.6 Hz, 2H), 
1.02 (t, J = 7.6 Hz, 3H), 0.01 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 168.33, 167.47, 148.80, 141.30, 
138.99, 136.53, 136.25, 134.65, 133.95, 131.44, 128.06, 127.77, 127.36, 123.36, 122.22, 121.74, 
117.46, 59.57, 36.04, 28.31, 15.43, -1.84; HRMS (ESI-TOF) calcd for C31H32N3O3Si (M+H)+: 
522.2207, found: 522.2217. 
X-ray Crystallographic Data of compound 3e   
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(2R,3S)-3-(4-chlorophenyl)-2-(1,3-dioxoisoindolin-2-yl)-N-(quinolin-8-yl)-3-
(trimethylsilyl)propanamide 3f 
1H NMR (400 MHz, CDCl3) δ 10.86 (br, 1H), 8.92 (dd, J = 4.0, 1.0 Hz, 1H), 8.80-8.75 (m, 1H), 
8.15 (dd, J = 8.4, 1.6 Hz, 1H), 7.74-7.69 (m, 2H), 7.63-7.60 m, 2H), 7.53-7.52 (m, 2H), 7.46 (dd, J 
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= 8.4, 4.0 Hz, 1H), 7.11 (d, J = 8.4 Hz, 2H), 7.05 (d, J = 8.8 Hz, 2H), 5.55 (d, J = 13.6 Hz, 1H), 3.91 
(d, J = 13.6 Hz, 1H), 0.01 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 168.22, 166.96, 148.83, 138.94, 
138.44, 136.32, 134.49, 134.26, 131.30, 131.19, 128.60, 128.08, 127.38, 123.59, 122.36, 121.81, 
117.47, 58.92, 35.99, -1.94; HRMS (ESI-TOF) calcd for C29H27ClN3O3Si (M+H)+: 528.1505, found: 
528.1505. 
 
(2R,3S)-2-(1,3-dioxoisoindolin-2-yl)-N-(quinolin-8-yl)-3-(4-(trifluoromethyl)phenyl)-3-
(trimethylsilyl)propanamide 3g 
1H NMR (400 MHz, CDCl3) δ 10.84 (br, 1H), 8.92 (dd, J = 4.0, 1.6 Hz, 1H), 8.79-8.77 (m, 1H), 
8.15 (dd, J = 8.0, 1.6 Hz, 1H), 7.71 (dd, J = 5.6, 3.2 Hz, 2H), 7.60 (dd, J = 5.6, 3.2 Hz, 2H), 7.53 (d, 
J = 4.4 Hz, 2H), 7.47 (dd, J = 8.4, 4.4 Hz, 1H), 7.40 (d, J = 8.2 Hz, 2H), 7.23 (d, J = 8.0 Hz, 2H), 
5.62 (d, J = 13.6 Hz, 1H), 4.04 (d, J = 13.6 Hz, 1H), 0.03 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
168.20, 166.75, 148.85, 144.39, 138.91, 136.34, 134.41, 134.30, 131.21, 128.25, 127.76 (q, J = 
32.2), 127.37, 125.37 (q, J = 3.8), 124.30 (q, J = 207.1), 123.60, 122.43, 121.84, 117.47, 58.60, 
36.75, -1.94; HRMS (ESI-TOF) calcd for C30H27F3N3O3Si (M+H)+: 562.1768, found: 562.1777. 
 
(2R,3S)-2-(1,3-dioxoisoindolin-2-yl)-3-(3-methoxyphenyl)-N-(quinolin-8-yl)-3-
(trimethylsilyl)propanamide 3h 
1H NMR (400 MHz, CDCl3) δ 10.93 (br, 1H), 8.93 (dd, J = 4.0, 1.6 Hz, 1H), 8.79 (dd, J = 5.2, 4.0 
Hz, 1H), 8.14 (dd, J = 8.4, 1.6 Hz, 1H), 7.70 (dd, J = 5.6, 3.2 Hz, 2H), 7.58 (dd, J = 5.6, 3.2 Hz, 
2H), 7.52 (d, J = 1.6 Hz, 1H), 7.51 (s, 1H), 7.46 (dd, J = 8.4, 4.4 Hz, 1H), 7.02 (t, J = 8.0 Hz, 1H), 
6.70 (d, J = 7.6 Hz, 1H), 6.66-6.65 (m, 1H), 6.51 (dd, J = 8.0, 2.0 Hz, 1H), 5.59 (d, J = 13.6 Hz, 
1H), 3.87 (d, J = 13.6 Hz, 1H), 3.71 (s, 3H), 0.03 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 168.27, 
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167.28, 159.48, 148.81, 141.27, 138.98, 136.27, 134.61, 134.08, 131.42, 129.31, 128.07, 127.36, 
123.45, 122.28, 121.76, 117.48, 111.80, 59.32, 55.25, 36.66, -1.82; HRMS (ESI-TOF) calcd for 
C30H30N3O4Si (M+H)+: 524.2000, found: 524.2000. 
NHO
N
N
SiMe3
O
O
Cl
NHAc
 
(2R,3S)-3-(4-acetamido-3-chlorophenyl)-2-(1,3-dioxoisoindolin-2-yl)-N-(quinolin-8-yl)-3-
(trimethylsilyl)propanamide 3i 
1H NMR (400 MHz, CDCl3) δ 10.84 (br, 1H), 8.92 (dd, J = 4.0, 1.6 Hz, 1H), 8.79-8.74 (m, 1H), 
8.18-8.13 (m, 2H), 7.73 (dd, J = 5.6, 3.2 Hz, 2H), 7.60 (dd, J = 5.6, 3.2 Hz, 2H), 7.52 (s, 1H), 7.51 
(d, J = 1.2 Hz, 1H), 7.46 (dd, J = 8.4, 4.0 Hz, 2H), 7.15 (d, J = 2.0 Hz, 1H), 7.02 (dd, J = 8.8, 2.0 
Hz, 1H), 5.53 (d, J = 13.6 Hz, 1H), 3.89 (d, J = 13.6 Hz, 1H), 2.14 (s, 3H), 0.02 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 168.14, 166.84, 148.84, 138.92, 136.66, 136.30, 134.45, 134.22, 132.28, 
131.33, 128.06, 127.35, 123.66, 122.37, 122.23, 121.82, 121.28, 117.46, 58.80, 35.80, 24.94, -1.91; 
HRMS (ESI-TOF) calcd for C31H30ClN4O4Si (M+H)+: 585.1719, found: 585.1725. 
 
(2R,3S)-3-(3,4-dimethoxyphenyl)-2-(1,3-dioxoisoindolin-2-yl)-N-(quinolin-8-yl)-3-
(trimethylsilyl)propanamide 3j 
1H NMR (400 MHz, CDCl3) δ 10.95 (br, 1H), 8.94 (dd, J = 4.0, 1.6 Hz, 1H), 8.79 (dd, J = 4.8, 4.0 
Hz, 1H), 8.15 (dd, J = 8.4, 1.6 Hz, 1H), 7.70 (dd, J = 5.6, 3.2 Hz, 2H), 7.59 (dd, J = 5.6, 3.2 Hz, 
2H), 7.53 (d, J = 1.2 Hz, 1H), 7.52 (s, 1H), 7.46 (dd, J = 8.0, 4.4 Hz, 1H), 6.65-6.61 (m, 3H), 5.54 
(d, J = 13.5 Hz, 1H), 3.81-3.78 (m, 4H), 3.72 (s, 3H), 0.03 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
168.36, 167.35, 148.81, 148.54, 146.72, 139.00, 136.29, 134.64, 134.16, 132.04, 131.40, 128.09, 
127.37, 123.47, 122.28, 121.75, 117.53, 111.15, 59.50, 55.90, 55.75, 35.90, -1.82; HRMS (ESI-
TOF) calcd for C31H32N3O5Si (M+H)+: 554.2106, found: 554.2108. 
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2-(1,3-dioxoisoindolin-2-yl)-N-(quinolin-8-yl)-3-(trimethylsilyl)butanamide 5k and 5k, 
3k:3k, = 3:1; 1H NMR (400 MHz, CDCl3) δ 10.75 (br, 0.75 H), 10.72 (br, 0.25 H), 8.92 (dd, J = 
4.0, 1.6 Hz, 0.25 H), 8.88 (dd, J = 4.4, 1.6 Hz, 0.75H), 8.78-8.72 (m, 1H), 8.14 (dd, J = 8.0, 1.6 Hz, 
1H), 7.91-7.86 (m, 2H), 7.75-7.70 (m, 2H), 7.53-7.48 (m, 2H), 7.44 (dd, J = 8.4, 4.0 Hz, 1H), 5.00 
(d, J = 12.0 Hz, 0.75H), 4.96 (d, J = 12.0 Hz, 0.25H), 2.63-2.56 (m, 0.25H), 2.44-2.35 (m, 0.75H), 
1.19 (d, J = 7.2 Hz, 0.75H), 0.99 (d, J = 7.6 Hz, 2.25H), 0.08 (s, 6.75H), -0.02 (s, 2.25H); 13C NMR 
(100 MHz, CDCl3) δ 168.53, 168.26, 167.67, 167.47, 148.72, 139.00, 138.94, 136.28, 134.56, 
134.52, 134.42, 134.37, 131.89, 131.72, 128.07, 127.40, 127.36, 123.80, 123.76, 122.09, 122.06, 
121.74, 117.27, 117.16, 60.67, 60.08, 20.02, 19.67, 13.17, 12.60, -2.46; HRMS (ESI-TOF) calcd 
for C24H26ClN3O3Si (M+H)+: 432.1738, found: 432.1743. 
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2.3.3 General Procedure for the Synthesis of β-Silyl-Proponic Acids via Pd-
Catalyzed Silylation of Primary C‒H Bonds (GP3) 
 
To an oven-dried 50 mL screw-capped vial was added substrate 5 (0.15 mmol), hexamethyldisilane 
(0.75 mmol), Pd(OAc)2 (3.5 mg, 0.015 mmol), s-BINA-PO2H (15.2 mg, 0.045 mmol), Ag2CO3 
(82.8 mg, 0.3 mmol), NaHCO3 (25.2 mg, 0.3 mmol), LiOAc (4.7 mg, 0.075 mmol), toluene (1.0 
mL). The mixture was stirred for 10 h at 125 °C under air followed by cooling. The resulting mixture 
was filtered through a celite pad and concentrated in vacuo. The residue was purified by preparative 
TLC using hexane/EtOAc as the eluent to afford the product 6.   
 
2-phenyl-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6a 
1H NMR (400 MHz, CDCl3) δ 9.93 (s, 1H), 8.75-8.73 (m, 2H), 8.08 (d, J = 8.0 Hz, 1H), 7.51-7.33 
(m, 7H), 7.27-7.24 (m, 1H), 3.83 (t, J = 8.0, 1H), 1.62 (dd, J = 14.4, 6.4 Hz, 1H), 1.35 (dd, J = 14.8, 
9.2 Hz, 1H), -0.07 (d, J = 0.8 Hz, 9H); 13C NMR (100 MHz, CDCl3) δ 173.22, 148.24, 141.71, 
138.61, 136.34, 134.73, 128.94, 128.11, 127.98, 127.47, 127.40, 121.60, 121.45, 116.37, 51.00, 
21.26, -1.15; HRMS (EI-TOF) calcd for C21H24N2OSi (M+): 348.1658, found: 348.1656. 
 
N-(quinolin-8-yl)-2-(o-tolyl)-3-(trimethylsilyl)propanamide 6b 
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1H NMR (400 MHz, CDCl3) δ 9.88 (br, 1H), 8.73 (d, J = 7.6 Hz, 1H), 8.68 (d, J = 4.0 Hz, 1H), 8.08 
(d, J = 8.4 Hz, 1H), 7.55-7.42 (m, 3H), 7.37 (dd, J = 8.0, 4.0 Hz, 1H), 7.25-7.15 (m, 3H), 4.09 (dd, 
J = 8.4, 7.2 Hz, 1H), 2.53 (s, 3H), 1.67 (dd, J = 14.8, 6.8 Hz, 1H), 1.33 (dd, J = 14.8, 8.8 Hz, 1H), -
0.05 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 173.31, 148.25, 139.78, 138.62, 136.27, 135.77, 134.82, 
130.94, 127.96, 127.70, 127.48, 127.19, 126.80, 121.58, 121.35, 116.24, 46.38, 20.62, 20.22, -1.03; 
HRMS (EI-TOF) calcd for C22H26N2OSi (M+): 362.1814, found: 362.1816. 
 
2-(2-fluorophenyl)-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6c 
1H NMR (400 MHz, CDCl3) δδ 10.04 (br, 1H), 8.76 (m, 2H), 8.11 (d, J = 8.0 Hz, 1H), 7.58 (t, J = 
7.2 Hz, 1H), 7.51-7.45 (m, 2H), 7.41 (dd, J = 8.0, 4.0 Hz, 1H), 7.24-7.13 (m, 2H), 7.07 (t, J = 8.8 
Hz, 1H), 4.24 (dd, J = 8.4, 7.2 Hz, 1H), 1.63 (dd, J = 14.4, 6.8 Hz, 1H), 1.34 (dd, J = 14.4, 8.8 Hz, 
1H), -0.05 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 172.31, 160.38 (d, J = 243.1 Hz), 148.38, 138.65, 
136.31, 134.75, 129.45 (d, J = 3.7 Hz), 128.81 (d, J = 8.3 Hz), 128.65 (d, J = 14.5 Hz), 128.00, 
127.46, 124.74 (d, J = 3.4 Hz), 121.67, 121.57, 116.49, 115.60 (d, J = 22.6 Hz), 42.14 (d, J = 2.4 
Hz), 42.13, 20.14, -1.23; 19F NMR (376 MHz, CDCl3) δ -118.26; HRMS (EI-TOF) calcd for 
C21H23FN2OSi (M+): 366.1564, found: 366.1557. 
 
2-(2-chlorophenyl)-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6d 
1H NMR (400 MHz, CDCl3) δ 10.07 (br, 1H), 8.77 (d, J = 4.0 Hz, 1H), 8.73 (d, J = 7.2 Hz, 1H), 
8.10 (d, J = 8.0 Hz, 1H), 7.63 (d, J = 7.6 Hz, 1H), 7.51-7.38 (m, 4H), 7.27 (t, J = 7.6 Hz, 1H), 7.17 
(t, J = 7.6 Hz, 1H), 4.48 (t, J = 7.6 Hz, 1H), 1.62 (dd, J = 14.8, 7.2 Hz, 2H), 1.33 (dd, J = 14.8, 8.4 
Hz, 1H), -0.04 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 172.21, 148.39, 139.31, 138.62, 136.28, 
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134.83, 133.52, 129.69, 129.29, 128.43, 127.99, 127.54, 127.44, 121.67, 121.57, 116.48, 45.75, 
20.66, -1.12; HRMS (EI-TOF) calcd for C21H23ClN2OSi (M+): 382.1268, found: 382.1273. 
 
N-(quinolin-8-yl)-2-(m-tolyl)-3-(trimethylsilyl)propanamide 6e 
1H NMR (400 MHz, CDCl3) δ 9.87 (br, 1H), 8.73 (d, J = 7.6 Hz, 1H), 8.68 (d, J = 4.0 Hz, 1H), 8.08 
(d, J = 8.4 Hz, 1H), 7.55-7.42 (m, 3H), 7.37 (dd, J = 8.4, 4.4 Hz, 1H), 7.25-7.16 (m, 3H), 4.09 (t, J 
= 8.0 Hz, 1H), 2.53 (s, 3H), 1.67 (dd, J = 14.8, 6.8 Hz, 1H), 1.33 (dd, J = 14.8, 8.8 Hz, 1H), -0.05 
(s, 9H); 13C NMR (100 MHz, CDCl3) δδ 173.32, 148.26, 139.78, 138.62, 136.28, 135.77, 134.82, 
130.94, 127.96, 127.70, 127.48, 127.19, 126.80, 121.58, 121.36, 116.24, 46.38, 20.62, 20.22, -1.03; 
HRMS (EI-TOF) calcd for C22H26N2OSi (M+): 362.1814, found: 362.1816. 
 
2-(3-chlorophenyl)-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6f 
1H NMR (400 MHz, CDCl3) δ 9.95 (br, 1H), 8.78 (d, J = 4.0 Hz, 1H), 8.73 (d, J = 7.2 Hz, 1H), 8.12 
(d, J = 8.4 Hz, 1H), 7.52-7.39 (m, 6H), 7.30-7.23 (m, 2H), 3.79 (t, J = 8.0 Hz, 1H), 1.62 (dd, J = 
14.4, 7.2 Hz, 1H), 1.30 (dd, J = 14.6, 8.5 Hz, 1H), -0.05 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
172.37, 148.37, 143.87, 138.60, 136.44, 134.73, 134.53, 130.15, 128.21, 128.02, 127.59, 127.50, 
126.30, 121.72, 121.68, 116.50, 50.70, 21.49, -1.13; HRMS (EI-TOF) calcd for C21H23ClN2OSi 
(M+): 382.1268, found: 382.1262. 
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N-(quinolin-8-yl)-2-(3-(trifluoromethyl)phenyl)-3-(trimethylsilyl)propanamide 6g 
1H NMR (400 MHz, CDCl3) δ 9.98 (br, 1H), 8.77 (d, J = 2.8 Hz, 1H), 8.72 (d, J = 6.0 Hz, 1H), 8.13 
(d, J = 8.4 Hz, 1H), 7.79 (s, 1H), 7.72 (d, J = 7.2 Hz, 1H), 7.54-7.42 (m, 5H), 3.89 (t, J = 8.0 Hz, 
1H), 1.66 (dd, J = 14.8, 7.2 Hz, 1H), 1.34 (dd, J = 14.7, 8.4 Hz, 1H), -0.05 (s, 9H); 13C NMR (100 
MHz, CDCl3) δδ 172.24, 148.38, 142.82, 138.61, 136.44, 134.46, 131.56, 131.22 (q, J = 32.0 Hz), 
129.39, 128.02, 127.48, 124.90 (q, J = 3.8 Hz), 124.29 (q, J = 3.7 Hz), 124.26 (q, J = 270.7 Hz), 
121.77, 116.52, 50.85, 21.68, -1.16; 19F NMR (376 MHz, CDCl3) δ -62.52; HRMS (EI-TOF) calcd 
for C22H23F3N2OSi (M+): 416.1532, found: 416.1533. 
 
2-(4-methoxyphenyl)-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6h 
1H NMR (400 MHz, CDCl3) δ 9.91 (br, 1H), 8.74 (d, J = 7.2 Hz, 2H), 8.11 (d, J = 8.4 Hz, 1H), 
7.51-7.40 (m, 5H), 6.89 (d, J = 8.0 Hz, 2H), 3.79-3.75 (m, 4H), 1.58 (dd, J = 14.4, 6.4 Hz, 2H), 1.33 
(dd, J = 14.4, 9.6 Hz, 1H), -0.07 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 173.65, 159.00, 148.26, 
138.66, 136.37, 134.82, 133.77, 129.12, 128.01, 127.52, 121.61, 121.40, 116.35, 114.34, 55.42, 
50.15, 21.25, -1.10; HRMS (EI-TOF) calcd for C22H26N2O2Si (M+): 378.1764, found: 378.1761. 
 
2-(4-fluorophenyl)-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6i 
1H NMR (400 MHz, CDCl3) δ 9.92 (br, 1H), 8.76-8.72 (m, 2H), 8.11 (d, J = 7.6 Hz, 1H), 7.52-7.45 
(m, 4H), 7.41 (dd, J = 8.0, 4.0 Hz, 1H), 7.04 (t, J = 8.4 Hz, 2H), 3.81 (dd, J = 8.4, 6.8 Hz, 1H), 1.60 
(dd, J = 14.8, 6.8 Hz, 1H), 1.32 (dd, J = 14.8, 8.8 Hz, 1H), -0.07 (s, 9H); 13C NMR (100 MHz, 
CDCl3) δ 173.05, 162.25 (d, J = 244.0 Hz), 148.32, 138.61, 137.49 (d, J = 3.1 Hz), 136.42, 134.62, 
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129.61 (d, J = 8.0 Hz,), 128.02, 127.49, 121.64 (d, J = 8.6 Hz,), 116.42, 115.86, 115.64, 50.22, 21.54, 
-1.13; HRMS (EI-TOF) calcd for C21H23FN2OSi (M+): 366.1564, found: 366.1566. 
 
2-(3,4-dichlorophenyl)-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6l 
1H NMR (400 MHz, CDCl3) δ 9.96 (br, 1H), 8.79 (dd, J = 4.0, 1.2 Hz, 1H), 8.71 (dd, J = 6.8, 2.0 
Hz, 1H), 8.13 (dd, J = 8.4, 1.2 Hz, 1H), 7.63 (d, J = 1.6 Hz, 1H), 7.53-7.35 (m, 5H), 3.78 (t, J = 8.0 
Hz, 1H), 1.61 (dd, J = 14.8, 7.6 Hz, 1H), 1.27 (dd, J = 14.8, 8.0 Hz, 1H), -0.03 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 171.94, 148.42, 142.18, 138.56, 136.47, 134.37, 132.86, 131.40, 130.76, 
129.96, 128.02, 127.47, 127.41, 121.83, 121.77, 116.55, 50.17, 21.62, -1.10; HRMS (EI-TOF) calcd 
for C21H22Cl2N2OSi (M+): 416.0878, found: 416.0876. 
 
2-(naphthalen-2-yl)-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6k 
1H NMR (400 MHz, CDCl3) δ 10.00 (br, 1H), 8.74 (d, J = 7.6 Hz, 1H), 8.66 (d, J = 4.0 Hz, 1H), 
8.08 (d, J = 8.4 Hz, 1H), 7.95 (s, 1H), 7.87-7.79 (m, 3H), 7.64 (d, J = 8.4 Hz, 1H), 7.51-7.42 (m, 
4H), 7.37 (dd, J = 8.0, 4.0 Hz, 1H), 4.01 (t, J = 8.0 Hz, 1H), 1.72 (dd, J = 14.8, 7.2 Hz, 1H), 1.44 
(dd, J = 14.8, 8.8 Hz, 1H), -0.06 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 173.08, 148.26, 139.30, 
138.61, 136.34, 134.72, 133.75, 132.88, 128.76, 127.96, 127.80, 127.49, 126.83, 126.26, 126.12, 
125.88, 121.61, 121.48, 116.37, 51.15, 21.22, -1.04; HRMS (EI-TOF) calcd for C25H26N2OSi (M+): 
398.1814, found: 398.1811. 
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2-(naphthalen-1-yl)-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6j 
1H NMR (400 MHz, CDCl3) δ 9.93 (br, 1H), 8.74 (d, J = 7.6 Hz, 1H), 8.55 (dd, J = 4.0, 1.6 Hz, 1H), 
8.31 (d, J = 8.4 Hz, 1H), 8.01 (dd, J = 8.0, 1.6 Hz, 1H), 7.86 (d, J = 8.0 Hz, 1H), 7.78 (dd, J = 12.4, 
7.6 Hz, 2H), 7.59-7.37 (m, 5H), 7.29 (dd, J = 8.0, 4.0 Hz, 1H), 4.64 (t, J = 7.6 Hz, 1H), 1.82 (dd, J 
= 14.8, 7.2 Hz, 1H), 1.52 (dd, J = 14.8, 8.4 Hz, 1H), -0.06 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
173.29, 148.13, 138.54, 137.63, 136.16, 134.77, 134.40, 131.69, 129.19, 128.14, 127.89, 127.41, 
126.61, 125.81, 125.77, 123.60, 121.50, 121.34, 116.17, 46.81, 20.75, -1.03; HRMS (EI-TOF) calcd 
for C25H26N2OSi (M+): 398.1814, found: 398.1811. 
 
2-methyl-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6m 
1H NMR (400 MHz, CDCl3) δ 9.89 (br, 1H), 8.82-8.78 (m, 2H), 8.15 (dd, J = 8.4, 1.2 Hz, 1H), 
7.55-7.43 (m, 3H), 2.77-2.68 (m, 1H), 1.37 (d, J = 6.8 Hz, 3H), 1.20 (dd, J = 14.8, 6.8 Hz, 1H), 0.88 
(dd, J = 14.8, 7.6 Hz, 1H), 0.06 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 176.41, 148.27, 138.65, 
136.48, 134.81, 128.08, 127.61, 121.67, 121.37, 116.54, 39.37, 22.49, 21.45, -0.84; HRMS (EI-
TOF) calcd for C16H22N2OSi (M+): 286.1501, found: 286.1496. 
 
N-(quinolin-8-yl)-2-((trimethylsilyl)methyl)butanamide 6n 
1H NMR (400 MHz, CDCl3) δ 9.86 (br, 1H), 8.81 (d, J = 7.2 Hz, 2H), 8.16 (d, J = 8.0 Hz, 1H), 
7.56-7.44 (m, 3H), 2.52-2.45 (m, 1H), 1.88-1.79 (m, 1H), 1.68-1.61 (m, 1H), 1.14 (dd, J = 14.8, 8.8 
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Hz, 1H), 0.99 (t, J = 7.2 Hz, 3H), 0.88 (dd, J = 14.8, 6.0 Hz, 1H), 0.03 (s, 9H); 13C NMR (100 MHz, 
CDCl3) 75.54, 148.31, 138.63, 136.47, 134.73, 128.10, 127.63, 121.68, 121.39, 116.59, 46.90, 29.68, 
20.73, 12.19, -0.96; HRMS (EI-TOF) calcd for C17H24N2OSi (M+): 300.1658, found: 300.1654. 
 
N-(quinolin-8-yl)-2-((trimethylsilyl)methyl)octanamide 6o 
1H NMR (400 MHz, CDCl3) δ 9.85 (br, 1H), 8.83-8.79 (m, 2H), 8.16 (dd, J = 8.0, 1.2 Hz, 1H), 
7.56-7.44 (m, 3H), 2.58-2.51 (m, 1H), 1.87-1.78 (m, 1H), 1.60-1.53 (m, 1H), 1.40-1.25 (m, 8H), 
1.13 (dd, J = 14.8, 8.8 Hz, 1H), 0.91-0.82 (m, 4H), 0.03 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
175.71, 148.30, 138.63, 136.45, 134.75, 128.09, 127.63, 121.67, 121.36, 116.59, 45.31, 36.74, 31.85, 
29.49, 27.69, 22.74, 21.11, 14.19, -0.94; HRMS (EI-TOF) calcd for C21H32N2OSi (M+): 356.2284, 
found: 356.2285. 
 
2-cyclohexyl-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6p 
1H NMR (400 MHz, CDCl3) δ 9.82 (br, 1H), 8.83-8.80 (m, 2H), 8.16 (d, J = 8.0 Hz, 1H), 7.55-7.44 
(m, 3H), 2.33-2.27 (m, 1H), 1.97 (d, J = 12.4 Hz, 1H), 1.79 (t, J = 13.2 Hz, 2H), 1.71-1.58 (m, 3H), 
1.28-0.90 (m, 7H), -0.01 (s, 9H).; 13C NMR (100 MHz, CDCl3) δ 174.81, 148.32, 138.62, 136.43, 
134.66, 128.10, 127.65, 121.66, 121.33, 116.54, 51.31, 43.40, 30.96, 30.79, 26.64, 26.59, 26.55, 
17.22, -1.14; HRMS (EI-TOF) calcd for C21H30N2OSi (M+): 354.2127, found: 354.2131. 
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2-((1S,4R)-bicyclo[2.2.1]heptan-2-yl)-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6q 
1H NMR (400 MHz, CDCl3) δ 9.85 (br, 1H), 9.81 (br, 1H), 8.83-8.76 (m, 2H), 8.16 (d, J = 8.0 Hz, 
1H), 7.56-7.44 (m, 3H), 2.27-2.09 (m, 3H), 1.81-1.74 (m, 1H), 1.60-1.27 (m, 5H), 1.11-0.81 (m, 
3H), -0.01 (d, J = 6.1 Hz, 9H); 13C NMR (100 MHz, CDCl3) δ 175.10, 174.84, 148.36, 138.65, 
138.61, 136.43, 136.42, 134.63, 128.10, 127.64, 121.67, 121.38, 121.35, 116.66, 116.63, 51.12, 
50.59, 48.96, 48.81, 39.89, 39.29, 37.22, 37.08, 36.86, 36.22, 35.85, 35.76, 30.56, 30.37, 28.81, 
20.86, 18.19, -1.12, -1.17; HRMS (ESI-TOF) calcd for C22H30N2OSi (M)+: 366.2127, found: 
366.2124. 
 
2-(2-chlorobenzyl)-N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6t 
1H NMR (400 MHz, CDCl3) δ 9.66 (br, 1H), 8.74-8.72 (m, 2H), 8.11 (dd, J = 8.0, 1.2 Hz, 1H), 
7.52-7.44 (m, 2H), 7.40 (dd, J = 8.0, 4.0 Hz, 1H), 7.33-7.31 (m, 1H), 7.26-7.23 (m, 1H), 7.04-7.02 
(dd, 2H), 3.20 (dd, J = 13.2, 8.4 Hz, 1H), 3.04 (dd, J = 13.2, 6.2 Hz, 1H), 3.01-2.94 (m, 1H), 1.26 
(dd, J = 14.8, 9.2 Hz, 1H), 0.90 (dd, J = 14.8, 4.8 Hz, 1H), 0.03 (s, 9H); 13C NMR (100 MHz, 
CDCl3) δ 174.35, 148.23, 138.50, 137.38, 136.28, 134.53, 134.16, 131.76, 129.63, 127.96, 127.93, 
127.49, 126.82, 121.62, 121.46, 116.60, 44.93, 40.67, 20.73, -1.02; HRMS (EI-TOF) calcd for 
C22H25ClN2OSi (M+): 396.1425, found: 396.1429. 
O
N
HN
SiMe3BnO  
6-(benzyloxy)-N-(quinolin-8-yl)-2-((trimethylsilyl)methyl)hexanamide 6r 
1H NMR (400 MHz, CDCl3) δ 9.86 (br, 1H), 8.81-8.78 (m, 2H), 8.16 (d, J = 8.0 Hz, 1H), 7.56-7.44 
(m, 3H), 7.28-7.23 (m, 5H), 4.45 (s, 2H), 3.46-3.42 (m, 2H), 2.59-2.52 (m, 1H), 1.90-1.81 (m, 1H), 
1.68-1.60 (m, 3H), 1.52-1.46 (m, 2H), 1.13 (dd, J = 14.8, 8.8 Hz, 1H), 0.87 (dd, J = 14.8, 6.0 Hz, 
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1H), 0.03 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 175.49, 148.32, 138.74, 138.63, 136.45, 134.71, 
128.44, 128.09, 127.76, 127.63, 127.57, 121.69, 121.42, 116.62, 73.01, 70.33, 45.26, 36.55, 29.92, 
24.38, 21.13, -0.94; HRMS (EI-TOF) calcd for C26H34N2O2Si (M+): 434.2390, found: 434.2397. 
 
N-(quinolin-8-yl)-8-(triisopropylsilyl)-2-((trimethylsilyl)methyl)oct-7-ynamide 6s 
1H NMR (400 MHz, CDCl3) δ 9.85 (br, 1H), 8.83-8.79 (m, 2H), 8.16 (d, J = 8.4 Hz, 1H), 7.56-7.44 
(m, 3H), 2.58-2.51 (m, 1H), 2.22 (t, J = 6.4 Hz, 2H), 1.88-1.79 (m, 1H), 1.60-1.42 (m, 7H), 1.14 
(dd, J = 14.4, 8.8 Hz, 1H), 1.04-0.94 (m, 21H), 0.88 (dd, J = 14.4, 8.8 Hz ,1H), 0.03 (s, 9H); 13C 
NMR (100 MHz, CDCl3) δ 175.54, 148.30, 138.63, 136.45, 134.71, 128.10, 127.62, 121.68, 121.39, 
116.62, 109.26, 80.21, 45.30, 36.63, 28.94, 28.85, 27.22, 21.14, 19.93, 18.77, 11.44, -0.93; HRMS 
(EI-TOF) calcd for C30H48N2OSi2 (M+):508.3305, found: 508.3299. 
 
(R)-2-((1S,2S,4aS)-1-methoxy-4a,8-dimethyl-7-oxo-1,2,3,4,4a,7-hexahydronaphthalen-2-yl)-
N-(quinolin-8-yl)-3-(trimethylsilyl)propanamide 6u 
1H NMR (400 MHz, CDCl3) δ 9.91 (br, 1H), 8.83 (dd, J = 4.0, 1.6 Hz, 1H), 8.75 (dd, J = 7.2, 1.2 
Hz, 1H), 8.14 (dd, J = 8.0, 1.2 Hz, 1H), 7.54-7.43 (m, 3H), 6.68 (d, J = 10.0 Hz, 1H), 6.21 (d, J = 
10.0 Hz, 1H), 4.03 (d, J = 11.2 Hz, 1H), 3.32-3.26 (m, 4H), 2.20 (s, 3H), 2.17-2.11 (m, 1H), 1.84-
1.79 (m, 3H), 1.31(s, 3H), 1.22-1.15 (m, 1H), 0.60 (dd, J = 14.0, 1.6 Hz, 1H), 0.05 (s, 9H); 13C 
NMR (100 MHz, CDCl3) δ 187.25, 173.90, 157.33, 156.55, 148.38, 138.60, 136.42, 134.82, 129.50, 
128.09, 127.51, 125.95, 121.73, 121.43, 116.50, 82.39, 58.42, 50.10, 44.08, 42.54, 39.23, 22.79, 
21.65, 12.23, 10.31, -1.13; HRMS (EI-TOF) calcd for C28H36N2O3Si (M+): 476.2495, found: 
476.2495. 
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(4R)-N-(quinolin-8-yl)-4-((3R,7R,10S,12S,13R,17R)-3,7,12-trimethoxy-10,13-
dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-
((trimethylsilyl)methyl)pentanamide 6v 
1H NMR (400 MHz, CDCl3) δ 9.84 (br, 1H), 8.83 (d, J = 4.0 Hz, 1H), 8.78 (d, J = 7.2 Hz, 1H), 8.15 
(dd, J = 8.0, 0.8 Hz, 1H), 7.55-7.44 (m, 3H), 3.38 (s, 1H), 3.32 (s, 3H), 3.23 (s, 3H), 3.20 (s, 3H), 
3.14 (d, J = 2.0 Hz, 1H), 3.02-2.95 (m, 1H), 2.60-2.55 (m, 1H), 2.18 (dd, J = 24.8, 12.8 Hz, 1H), 
2.11-1.43 (m, 15H), 1.34-1.15 (m, 4H), 1.07-0.83 (m, 10H), 0.69 (s, 3H), 0.02 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 176.18, 148.30, 138.65, 136.42, 134.87, 128.08, 127.63, 121.65, 121.28, 
116.58, 82.16, 80.87, 77.10, 55.99, 55.84, 55.51, 47.54, 46.47, 43.19, 42.90, 42.81, 42.12, 39.79, 
35.41, 35.06, 34.56, 34.37, 28.13, 28.00, 27.93, 26.88, 23.36, 23.02, 22.13, 19.78, 17.96, 12.66, -
0.98; HRMS (EI-TOF) calcd for C40H62N2O4Si (M+): 662.4479, found: 662.4484. 
2.4 Gram-scale reaction 
 
To an oven-dried 50 mL screw-capped vial was added substrate 1 (3 mmol), 2a hexamethyldisilane 
(15 mmol), Pd(OAc)2 (69 mg, 0.3 mmol), N-Boc-Val-OH (129.75 mg, 0.6 mmol), Ag2CO3 (1.656 
g, 6 mmol), t-BuOH (30 mL). The mixture was stirred for 10 h at 125 °C under air followed by 
cooling. The resulting mixture was filtered through a celite pad and concentrated in vacuo. The 
residue was purified by column chromatography using hexane/EtOAc as the eluent to afford the 
product (1.0 g, 80%) 1a. 
 
2.5 Removal of directing group 
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(R)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-(trimethylsilyl)propanoate 1aa 
To an oven-dried 50 mL screw-capped vial was added 1 (0.10 mmol), Et2O.BF3 (2.0 mmol) and 
MeOH (1mL). The mixture was stirred for 20 h at 120 °C under air followed by cooling. The 
resulting mixture was filtered through a celite pad and concentrated in vacuo. The residue was 
purified by preparing TLC using hexane/EtOAc=5:1 as the eluent to afford the product 1a (18.5 mg, 
62%). 1H NMR (400 MHz, CDCl3) δ 7.88-7.83 (m, 2H), 7.75-7.71 (m, 2H), 4.95 (dd, J=11.6, 4.8, 1H), 
3.71 3.71 (s, 3H), 1.71 (dd, J=15.2, 11.6, 1H), 1.54 (dd, J=15.2, 4.8, 1H), -0.04 (s, 9H); 13C NMR (100 
MHz, CDCl3) δ 171.24, 167.72, 134.32, 131.98, 123.64, 52.94, 49.32, 17.21, -1.47; HPLC Chiralpack® 
AD-H column (n-hexane/isopropanol = 70:30, 1.0 mL/min) tr = 4.389 min (major), tr = 5.116 min 
(minor): 99% ee. 
DL-/L-1aa 
 
Chiral stationary phase: Chiralpack® AD-H, n-hexane/isopropanol = 70:30, 1.0 mL/min  
Signal: VWD1 A, Wavelength = 220 nm 
       
Area% report for DL/L-1aa: 
DL-1aa L-1aa 
Retention Time 
(min) 
Area 
(mAU*s) Area %
Retention Time 
(min) Area (mAU*s) 
Area 
% 
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4.219 3238662 50.23 4.389 4195545 99.88
5.103 3209038 49.77 5.116 5133 0.12 
Totals 6447700 100.00 Totals 4200677 100.00
 
 
Scheme S1. Removal of AQ auxiliary 
(2R,3S)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-phenyl-3-(trimethylsilyl)propanoate 4a 
To an oven-dried 50 mL screw-capped vial was added 2a (0.10 mmol), Et2O.BF3 (2.0 mmol) and 
MeOH (1mL). The mixture was stirred for 20 h at 120 °C under air followed by cooling. The 
resulting mixture was filtered through a celite pad and concentrated in vacuo. The residue was 
purified by preparing TLC using hexane/EtOAc=5:1 as the eluent to afford the product 4a (25.1 mg, 
66%). 1H NMR (400 MHz, CDCl3) δ 7.68-7.65 (m, 2H), 7.61-7.58 (m, 2H), 7.06 (t, J = 7.6 Hz, 
2H), 6.97-6.90 (m, 3H), 5.42 (d, J = 13.6 Hz, 1H), 3.75 (s, 3H), 3.58 (d, J = 13.6 Hz, 1H), 0.02 (s, 
9H); 13C NMR (100 MHz, CDCl3) δ 169.98, 167.60, 140.13, 133.98, 131.49, 128.26, 125.42, 
123.34, 54.24, 52.85, 36.26, -1.21. HPLC Chiralpack® AD-H column (n-hexane/isopropanol = 
70:30, 1.0 mL/min) tr = 4.135 min (minor), tr = 5.004 min (major): 97% ee. 
DL-/L-4a 
 
Chiral stationary phase: Chiralpack® AD-H, n-hexane/isopropanol = 70:30, 1.0 mL/min  
Signal: VWD1 A, Wavelength = 220 nm 
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Area% report for DL/L-3aa: 
DL-3aa L-3aa 
Retention Time 
(min) 
Area 
(mAU*s) Area %
Retention Time 
(min) Area (mAU*s) 
Area 
% 
4.156 2252574 51.04 4.135 147228 1.44 
4.989 2161197 48.96 5.004 10063255 98.56
Totals 4413771 100.00 Totals 10210484 100.00
 
7
NH
O
Ph Q
O
Ph N(Boc)2O, DMAP
6a
6aa, 75 % (for 2 steps)
O
Ph OHNaOH, H2O
CH3CN
Q
Boc
7
TMS TMS
O
Ph N Q
BocTMS TMS
 
6a (0.470 mmol) was placed in a 50 mL round-bottomed flask, and the flask was flushed with 
nitrogen. Dichloromethane (5.0 mL) and Boc2O (0.825 g, 3.78 mmol) were added. N,N-Dimethyl-
4-aminopyridine (0.287 g, 2.35 mmol) was added in one portion and the resulting solution was 
refluxed for 30 h. The reaction mixture was concentrated in vacuo, followed by column 
chromatography on silica gel (hexane/ethyl acetate) gave 7. [4] 1H NMR (400 MHz, CDCl3) δ 8.88 
(d, J = 2.4 Hz, 1H), 8.16 (dd, J = 8.4, 1.6 Hz, 1H), 7.80 (dd, J = 8.0, 0.8 Hz, 1H), 7.49 (t, J = 8.0 
Hz, 1H), 7.43-7.23 (m, 7H), 1.55 (dd, J = 14.8, 6.0 Hz, 1H), 1.31 (dd, J = 14.8, 9.6 Hz, 1H), 1.22 
(s, 9H), -0.10 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 178.22, 152.84, 150.28, 144.44, 141.83, 
137.50, 135.93, 128.78, 128.59, 128.38, 127.86, 126.94, 126.09, 121.50, 82.24, 47.14, 27.62, 22.10, 
-1.15. 
To an oven-dried 50 mL screw-capped vial was added 7 (0.10 mmol), NaOH (1.0 mmol) and H2O 
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(1mL). The mixture was stirred for 20 h at 120 °C under air followed by cooling. The resulting 
mixture was HCl (1M) and ethyl acetate. The mixture was extracted with EA (10 ml ×2) and dried 
with Na2SO4, then concentrated in vacuo. The residue was purified by preparing TLC using 
hexane/EtOAc as the eluent to afford the product 6aa (16.6 mg, 75% for 2 steps). [5] 1H NMR (400 
MHz, CDCl3) δ 7.33-7.23 (m, 5H), 3.63 (t, J = 8.0 Hz, 1H), 1.36 (dd, J = 14.8, 7.2 Hz, 1H), 1.15 
(dd, J = 14.8, 8.8 Hz, 1H), -0.13 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 181.32, 140.50, 128.69, 
128.18, 127.50, 47.56, 21.21, -1.32. 
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2.6 Mechanistic Investigations 
2.6.1 Mechanistic Investigations of Pd-Catalyzed Silylation of α-AAs 
 
Scheme S2. Mechanistic investigations of Pd-catalyzed silylation of α-amino acids 
 
Synthesis of Palladacycle Int-A 
NHNPhth
H O
Q
PhthN
O
N
NPdII
MeCN
Int-A, 91%1
Pd(OAc)2
DCE-MeCN
 
Pd(OAc)2 (224.5 mg, 1.0 mmol) and 1 (345.4 mg, 1.0 mmol) were added to CH3CN/DCE (12 mL+6 
mL). The reaction was stirred at 50 oC for 4 h, and then the solvent was removed under vacuum. To 
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the crude product, 3 mL of CH2Cl2 was added, followed by 10 mL of petroleum ether, and then the 
purified product was collected by filtration, washed with petroleum ether, and dried under vacuum 
to afford Int-A (446.6 mg, 91%) as a yellow powder. A single crystal suitable for X-ray diffraction 
was obtained. 
X-ray Crystallographic Data of Int-A   
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Stoichimetric reaction of intermediate Int-A 
 
To an oven-dried 50 mL screw-capped vial was added substrate Int-A (0.05 mmol), 
hexamethyldisilane (0.25 mmol), Ag2CO3 (0.025 mmol), 2,6-diMeO-BQ (0.075 mmol), 1,4-
dioxane (1.0 mL). The mixture was stirred for 12 h at 125 °C under air followed by cooling. The 
resulting mixture was filtered through a celite pad and concentrated in vacuo. The residue was 
purified by preparative TLC using hexane/EtOAc as the eluent to afford the product 1a was obtained 
in 75% yield (determined by 1H NMR). 
Catalytic reaction of intermediate Int-A 
H
NPhth
O
NH
Q
1
10 mol% Int-A H
NPhth
O
NH
Q
TMSH
1a, 64%
Condition A
(Me3Si)2
 
To an oven-dried 50 mL screw-capped vial was added substrate 1 (0.1 mmol), hexamethyldisilane 
(0.5 mmol), Int-A (0.01 mmol), Ag2CO3 (0.05 mmol), 2,6-diMeO-BQ (0.15 mmol), 1,4-dioxane 
(1.0 mL). The mixture was stirred for 12 h at 125 °C under air followed by cooling. The resulting 
mixture was filtered through a celite pad and concentrated in vacuo. The residue was purified by 
preparative TLC using hexane/EtOAc as the eluent to afford the product 1a was obtained in 64% 
yield (determined by 1H NMR). 
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Synthesis of the Palladacycle Int-B[6] 
 
Pd(OAc)2 (224.5 mg, 1.0 mmol) and 2a (421.5 mg, 1.0 mmol) were added to CH3CN/DCE (12 
mL+6 mL). The reaction was stirred at 50 oC for 4 h, and then the solvent was removed under 
vacuum. To the crude product, 3 mL of CH2Cl2 was added, followed by 10 mL of petroleum ether, 
and then the purified product was collected by filtration, washed with petroleum ether, and dried 
under vacuum to afford Int-B (550.2 mg, 97% yield, dr > 25:1 estimated by 1 H NMR) as a yellow 
powder. INT-D is a known compound.[6] 
Stoichimetric reaction of intermediate Int-B 
 
To an oven-dried 50 mL screw-capped vial was added substrate Int-B (0.05 mmol), 
hexamethyldisilane (0.25 mmol), Ag2CO3 (0.025 mmol), 2,6-diMeO-BQ (0.075 mmol), 1,4-
dioxane (1.0 mL). The mixture was stirred for 12 h at 125 °C under air followed by cooling. The 
resulting mixture was filtered through a celite pad and concentrated in vacuo. The residue was 
purified by preparative TLC using hexane/EtOAc as the eluent to afford the product 3a was obtained 
in 28% yield (determined by 1H NMR). 
Catalytic reaction of intermediate Int-B 
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To an oven-dried 50 mL screw-capped vial was added substrate 2a (0.1 mmol), hexamethyldisilane 
(0.5 mmol), Int-B (0.015 mmol), Ag2CO3 (0.05 mmol), 2,6-diMeO-BQ (0.15 mmol), 1,4-dioxane 
(1.0 mL). The mixture was stirred for 12 h at 125 °C under air followed by cooling. The resulting 
mixture was filtered through a celite pad and concentrated in vacuo. The residue was purified by 
preparative TLC using hexane/EtOAc as the eluent to afford the product 3a was obtained in 35% 
yield (determined by 1H NMR). 
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2.6.2 Experimental Investigations of the Origin of Site-Selective C-H 
Silylation of 2-APA 
Synthesis of Int-C and Int-D 
 
To an oven-dried 50 mL screw-capped vial was added substrate 1a (0.1 mmol), ligand (0.2 mmol), 
Pd(OAc)2 (0.1 mmol) in toluene (1 mL). The mixture was stirred for 12 h at 125 °C under N2 
followed by cooling. The resulting mixture was concentrated in vacuo. The residue was purified by 
preparative TLC using DCM/MeOH as the eluent to afford Int-C (20.6 mg, 41%) and Int-D (6.5 
mg, 13%). Int-C and Int-D were yellow-brownish solids that are stable at ambient temperature and 
decomposed slowly in solution.  
Int-C: 1H NMR (400 MHz, CDCl3) δ 9.16 (d, J = 8.0 Hz, 1H), 8.14 (d, J = 8.4 Hz, 1H), 7.61 (d, 
J = 3.6 Hz, 1H), 7.50-7.45 (m, 3H), 7.28-7.23 (m, 3H), 7.21-7.14 (m, 2H), 7.00 (s, 1H), 6.96 (s, 1H), 
4.01 (t, J = 7.6 Hz, 1H), 3.12 (s, 3H), 3.00 (s, 3H), 2.32 (s, 3H), 1.88 (t, J = 8.8 Hz, 1H), 1.57 (dd, J 
= 9.2, 7.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 185.62, 159.39, 159.37, 149.41, 147.53, 146.86, 
145.79, 145.05, 137.82, 130.03, 129.30, 128.21, 128.06, 125.53, 123.38, 120.98, 120.62, 118.21, 
60.10, 27.58, 27.48, 20.84, 14.22; HRMS (ESI-TOF) calcd for C26H26N3OPd (M+H)+: 502.1105, 
found: 502.1101. 
Int-D: 1H NMR (400 MHz, CDCl3) δ 8.95 (d, J=8.0, 1H), 8.20 (dd, J=8.0, 1.2, 1H), 7.57 (t, 
J=8.0, 1H), 7.32-7.29 (m, 2H), 7.21-7.18 (m, 2H), 7.10 (s, 1H), 7.05 (d, J=7.2, 1H), 6.93 (t, J=6.8, 1H), 
6.66 (td, J=7.2, 1.2, 1H), 6.22 (dd, J=7.2, 0.8, 1H), 4.04 (q, J=6.8, 1H), 3.09 (s, 3H), 2.97 (s, 3H), 2.45 
(s, 3H), 2.02 (d, J=6.8, 3H); 13C NMR (100 MHz, CDCl3) δ178.63, 159.95, 158.98, 150.57, 150.47, 
148.05, 144.54, 144.31, 141.93, 138.30, 134.31, 129.50, 129.45, 126.02, 125.00, 124.67, 124.50, 124.15, 
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124.02, 120.61, 118.57, 58.10, 28.52, 27.59, 26.28, 21.09; HRMS (ESI-TOF) calcd for C26H26N3OPd 
(M+H)+: 502.1105, found: 502.1108. 
 
To an oven-dried 50 mL round-bottomed flask was added substrate 5a (0.5 mmol), 2,4,6-
trimethylpyridine (1.0 mmol), Pd(OAc)2 (0.5 mmol) in toluene (10 mL). The flask was flushed with 
nitrogen and stirred for 12 h at 50 °C under N2 followed by cooling. The purified product was 
collected by filtration, washed with toluene, diethyl ether and dried under vacuum to afford a yellow 
powder, which was a mixture of Int-B and 2,4,6-collidine·HOAc salt. The mixture was purified by 
preparing TLC (EA:DCM:PE = 4:1:2 as the eluent) to afford Int-D (155.6 mg, 62%) as yellow 
powder. 
To an oven-dried 50 mL screw-capped vial was added Int-D (0.1 mmol) in toluene (1 mL). The 
mixture was stirred for 12 h at 125 °C under N2 followed by cooling. The resulting mixture was 
concentrated in vacuo. The residue was purified by preparative TLC (EA:DCM:PE = 4:1:2 as the 
eluent) to afford Int-C (7.5 mg, 15%) as yellow powder and recovered 5a (52%). 
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Scheme S3. Stoichimetric reaction of intermediate Int-C and Int-D 
Stoichimetric reaction of intermediate Int-C 
 
To an oven-dried 50 mL screw-capped vial was added Int-C (0.1 mmol), 2 (0.5 mmol), s-BINA-
PO2H (0.03 mmol), Ag2CO3 (0.2 mmol), NaHCO3 (0.2 mmol), LiOAc (0.05 mmol), toluene (1.0 
mL). The mixture was stirred for 10 h at 125 °C under air followed by cooling. The resulting mixture 
was filtered through a celite pad and concentrated in vacuo. The product 6a was obtained in 46% 
yield (determined by 1H NMR).  
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Stoichimetric reaction of intermediate Int-D at 125 °C 
Int-D
H N
O
NPd
N
O
NH
SiMe3
6a, 51%
Q
H
O
NH
6ab, 0%
Q
SiMe3
H
+Me3Si SiMe3
Condition C
 
To an oven-dried 50 mL screw-capped vial was added Int-D (0.1 mmol), 2 (0.5 mmol), s-BINA-
PO2H (0.03 mmol), Ag2CO3 (0.2 mmol), NaHCO3 (0.2 mmol), LiOAc (0.05 mmol), toluene (1.0 
mL). The mixture was stirred for 10 h at 125 °C under air followed by cooling. The resulting mixture 
was filtered through a celite pad and concentrated in vacuo. The product 6a was obtained in 51% 
yield and 6ab (0%) (determined by 1H NMR). 
 
Stoichimetric reaction of intermediate Int-D at 50 °C 
 
To an oven-dried 50 mL screw-capped vial was added Int-D (0.05 mmol), 2 (0.25 mmol), s-BINA-
PO2H (0.015 mmol), Ag2CO3 (0.1 mmol), NaHCO3 (0.1 mmol), LiOAc (0.025 mmol), toluene (1.0 
mL). The mixture was stirred for 10 h at 50 °C under air followed by cooling. The resulting mixture 
was filtered through a celite pad and concentrated in vacuo. 5a was isolated in 26% yield and no 
silylation products 6a and 6ab was observed in crude 1H NMR. 
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4. NMR Spectra 
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